Bridgeway Capital Management, LLC Sensei Biotherapeutics, Inc. Transaction History
Bridgeway Capital Management, LLC
- $4.76 Billion
- Q1 2024
A detailed history of Bridgeway Capital Management, LLC transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 112,900 shares of SNSE stock, worth $82,417. This represents 0.0% of its overall portfolio holdings.
Number of Shares
112,900
Previous 112,900
-0.0%
Holding current value
$82,417
Previous $77,000
53.25%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SNSE
# of Institutions
27Shares Held
2.32MCall Options Held
0Put Options Held
0-
Newtyn Management, LLC New York, NY930KShares$679,0670.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA574KShares$418,9060.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny211KShares$154,0300.0% of portfolio
-
Geode Capital Management, LLC Boston, MA136KShares$99,5120.0% of portfolio
-
Bank Of America Corp Charlotte, NC90.8KShares$66,2560.0% of portfolio
About Sensei Biotherapeutics, Inc.
- Ticker SNSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,720,300
- Market Cap $22.4M
- Description
- Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...